Clarity Pharmaceuticals was featured in Gamma Gazette, a journal and newsletter issued by the Australian and New Zealand Society of Nuclear Medicine (ANZSNM), which provides a unique educational resource for all those working in the field of nuclear medicine as well as a means of publication for individual members’ research work.
The article discusses the global nuclear medicine market, highlighting the constraints to its growth posed by supply and distribution of radioisotopes. It then goes on to examine how using the “perfect radioisotope pairing” of copper-64 for imaging and copper-67 for therapy solves some of these impediments and opens new opportunities for radiopharmaceutical development.
Read the full article here:
http://www.anzsnm.org.au/activities/gamma-gazette/
